GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a substantial development in how we handle diabetes mellitus . These new therapies help mimicking the body’s inherent GLP-1 process, https://active-bookmarks.com/story21631576/glp-1-a-significant-advance-in-diabetes-care